sitagliptin / metformin hydrochloride sun
sun pharmaceutical industries europe b.v. - sitagliptin fumarate, metformin hydrochloride - diabetes mellitus, tyyppi 2 - diabeetilla käytettävät lääkkeet - for adult patients with type 2 diabetes mellitus:sitagliptin/metformin hydrochloride sun is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. sitagliptin/metformin hydrochloride sun is indicated in combination with a sulphonylurea (i. kolmen lääkkeen yhdistelmähoito) lisänä ruokavalion ja liikunnan ohella potilaille riittävästi hallinnassa heidän maksimaalinen siedetty annos metformiinia ja sulfonyyliureaa. sitagliptin/metformin hydrochloride sun is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparγ agonist. sitagliptin/metformin hydrochloride sun is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.
valsartan/hydrochlorothiazide teva 160 mg / 12.5 mg tabletti, kalvopäällysteinen
teva sweden ab - hydrochlorothiazidum,valsartanum - tabletti, kalvopäällysteinen - 160 mg / 12.5 mg - valsartaani ja diureetit
valsartan/hydrochlorothiazide amneal 160 mg / 25 mg tabletti, kalvopäällysteinen
amneal pharma europe limited - valsartanum,hydrochlorothiazidum - tabletti, kalvopäällysteinen - 160 mg / 25 mg - valsartaani ja diureetit
sitagliptin / metformin hydrochloride accord
accord healthcare s.l.u. - metformin hydrochloride, sitagliptin hydrochloride monohydrate - diabetes mellitus, tyyppi 2 - diabeetilla käytettävät lääkkeet - for adult patients with type 2 diabetes mellitus:it is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. it is indicated in combination with a sulphonylurea (i. kolmen lääkkeen yhdistelmähoito) lisänä ruokavalion ja liikunnan ohella potilaille riittävästi hallinnassa heidän maksimaalinen siedetty annos metformiinia ja sulfonyyliureaa. it is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparγ agonist. it is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.
valsartan/hydrochlorothiazide teva 160 mg / 25 mg tabletti, kalvopäällysteinen
teva sweden ab - hydrochlorothiazidum,valsartanum - tabletti, kalvopäällysteinen - 160 mg / 25 mg - valsartaani ja diureetit
losartan/hydrochlorothiazide bluefish 100 mg / 25 mg tabletti, kalvopäällysteinen
bluefish pharmaceuticals ab - hydrochlorothiazidum,losartanum kalicum - tabletti, kalvopäällysteinen - 100 mg / 25 mg - losartaani ja diureetit
valsartan/hydrochlorothiazide ratiopharm 320 mg / 25 mg tabletti, kalvopäällysteinen
ratiopharm gmbh - hydrochlorothiazidum,valsartanum - tabletti, kalvopäällysteinen - 320 mg / 25 mg - valsartaani ja diureetit
valsartan/hydrochlorothiazide teva 320 mg / 12.5 mg tabletti, kalvopäällysteinen
teva sweden ab - hydrochlorothiazidum,valsartanum - tabletti, kalvopäällysteinen - 320 mg / 12.5 mg - valsartaani ja diureetit
valsartan/hydrochlorothiazide teva 320 mg / 25 mg tabletti, kalvopäällysteinen
teva sweden ab - hydrochlorothiazidum,valsartanum - tabletti, kalvopäällysteinen - 320 mg / 25 mg - valsartaani ja diureetit
candesartan/hydrochlorothiazide teva 8 mg / 12.5 mg tabletti
teva pharma b.v. - hydrochlorothiazidum,candesartanum cilexetilum - tabletti - 8 mg / 12.5 mg - kandesartaani ja diureetit